An assessment of a toxicological incident in a drug development program and its implications
- 1 March 1985
- journal article
- research article
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 5 (1) , 109-119
- https://doi.org/10.1016/0273-2300(85)90024-8
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Species differences in pharmacokineticsVeterinary Research Communications, 1983
- The mechanism of hepatotoxicity of a chromone carboxylic acid (FPL 52757) in the dogXenobiotica, 1982
- Metabolism and excretion of a chromone carboxylic acid (FPL 52757) in various animal speciesXenobiotica, 1982
- Characteristics and differences in the hepatic mixed function oxidase of different speciesPharmacology & Therapeutics, 1979
- Pharmacokinetics of perhexiline maleate in anginal patients with and without peripheral neuropathyEuropean Journal of Clinical Pharmacology, 1978
- New orally effective chromone derivatives for the treatment of asthmaInflammation Research, 1977
- The effect of diet on the toxicity of paracetamol and the safety of paracetamol-methionine mixturesBiochemical Pharmacology, 1975
- The Thalidomide Tragedy in Germany: The End of a Historic Medicolegal TrialNew England Journal of Medicine, 1971
- METABOLISM OF TOXIC SUBSTANCESBritish Medical Bulletin, 1969
- Species, strain and sex differences in metabolism of hexobarbitone, amidopyrine, antipyrine and anilineBiochemical Pharmacology, 1958